Ken Griffin Athenex, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $121,926 - $563,912	-508,029 Reduced 86.81%	77,162 $20,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $199,107 - $441,921	485,628 Added 487.76%	585,191 $240,000
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $32,352 - $65,115	-40,953 Reduced 29.14%	99,563 $82,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $531,171 - $1.15 Million	-390,567 Reduced 73.54%	140,516 $191,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $1.06 Million - $1.72 Million	355,253 Added 202.04%	531,083 $1.6 Million
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $175,112 - $242,136	-47,200 Reduced 21.16%	175,830 $812,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $726,807 - $2.63 Million	178,139 Added 396.83%	223,030 $959,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $2.22 Million - $2.81 Million	-200,360 Reduced 81.7%	44,891 $497,000
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $1.04 Million - $1.48 Million	101,629 Added 70.76%	245,251 $2.97 Million
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $1.62 Million - $3.14 Million	-228,359 Reduced 61.39%	143,622 $1.98 Million
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $2.31 Million - $6.41 Million	-404,118 Reduced 52.07%	371,981 $2.88 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $6.03 Million - $11.2 Million	628,267 Added 424.99%	776,099 $11.9 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $552,489 - $954,135	45,435 Added 44.37%	147,832 $1.8 Million
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $817,588 - $1.71 Million	-86,609 Reduced 45.82%	102,397 $2.03 Million
Q1 2019 May 15, 2019	SELL	$11.11 - $13.49 $357,864 - $434,526	-32,211 Reduced 14.56%	189,006 $0
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $1.23 Million - $1.87 Million	120,484 Added 119.61%	221,217 $2.81 Million
Q3 2018 Nov 13, 2018	SELL	$15.53 - $19.97 $314,746 - $404,731	-20,267 Reduced 16.75%	100,733 $0
Q2 2018 Aug 10, 2018	BUY	$15.88 - $19.5 $1.92 Million - $2.36 Million	121,000 New	121,000 $0

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account